Concentrations of the Stress Hormone Copeptin Increase upon Hypoglycaemia in Patients with Type 1 Diabetes Dependent of Hypoglycaemia Awareness

被引:12
|
作者
Seelig, Eleonora [1 ]
Bilz, Stefan [2 ]
Keller, Ulrich [1 ]
Meienberg, Fabian [1 ]
Christ-Crain, Mirjam [1 ]
机构
[1] Univ Basel Hosp, Dept Diabetol Endocrinol & Metab, CH-4031 Basel, Switzerland
[2] Kantonsspital, Dept Endocrinol, St Gallen, Switzerland
来源
PLOS ONE | 2013年 / 8卷 / 08期
关键词
INSULIN-INDUCED HYPOGLYCEMIA; ARGININE-VASOPRESSIN; STABLE PEPTIDE; PRECURSOR; PLASMA; SECRETION; RESPONSES; FAILURE; ASSAY;
D O I
10.1371/journal.pone.0072876
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Copeptin, a marker for stress mirroring vasopressin concentrations, has been shown to increase upon insulin-induced hypoglycaemia in patients after transsphenoidal surgery of pituitary adenomas. Patients with type 1 diabetes mellitus are prone to hypoglycaemia, but no data about copeptin levels upon hypoglycaemia are available. Furthermore, the perception of hypoglycaemia can vary from total unawareness to disabling episodes. The aim of this study was to investigate whether copeptin increases upon hypoglycaemia in patients with type 1 diabetes mellitus and is associated with the degree of hypoglycaemia awareness. Materials and Methods: In this prospective observational study, 17 patients with type 1 diabetes underwent a standardized insulin infusion test. Blood sampling for glucose and copeptin was performed at baseline and after 60 minutes (min). To assess hypoglycaemia associated symptoms the Mood and Symptom Questionnaire (MSQ) was conducted at baseline and after 60 min. Results: During insulin infusion, blood glucose decreased from 5.1 (SD +/- 0.2) to 3.0 (+/- 0.5) mmol/L at 60 min (p<0.001). Copeptin concentrations increased from 3.2 (+/- 1.7) to 3.8 (+/- 1.9) pmol/L (p = 0.03). Mood and Symptoms Questionnaire scores increased from 14 (+/- 3.0) to 18 (+/- 5.8), (p = 0.006). Patients with good hypoglycaemia awareness had an increase in copeptin from 3.0 (+/- 1.8) to 4.2 (+/- 2.4) pmol/L (p = 0.03) in contrast to patients more unaware of hypoglycaemia who only showed an increase in copeptin from 3.3 (+/- 1.6) to 3.6 (+/- 1.4) pmol/L (p = 0.4). There was a trend to a larger copeptin increase in patients aware of hypoglycemia compared to patients unaware of hypoglycemia (p = 0.074). Conclusion: Copeptin increases in patients with type 1 diabetes upon insulin induced hypoglycaemia. Interestingly, the copeptin increase seems associated with the degree of hypoglycaemia awareness. This hypothesis warrants further verification.
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Hypoglycaemia symptoms and impaired awareness of hypoglycaemia in adults with Type 1 diabetes: the association with diabetes duration
    Olsen, S. E.
    Asvold, B. O.
    Frier, B. M.
    Aune, S. E.
    Hansen, L. I.
    Bjorgaas, M. R.
    DIABETIC MEDICINE, 2014, 31 (10) : 1210 - 1217
  • [2] Evaluation of Hypoglycaemia with Non-Invasive Sensors in People with Type 1 Diabetes and Impaired Awareness of Hypoglycaemia
    Elvebakk, Ole
    Tronstad, Christian
    Birkeland, Kare I.
    Jenssen, Trond G.
    Bjorgaas, Marit R.
    Froslie, Kathrine F.
    Godang, Kristin
    Kalvoy, Havard
    Martinsen, Orjan G.
    Gulseth, Hanne L.
    SCIENTIFIC REPORTS, 2018, 8
  • [3] Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: Hypoglycaemia fear, glycaemic and pregnancy outcomes
    Bahrami, Jasmine
    Tomlinson, George
    Murphy, Helen R.
    Feig, Denice S.
    DIABETIC MEDICINE, 2022, 39 (05)
  • [4] Hypoglycaemia and rebound hyperglycaemia increase left ventricular systolic function in patients with type 1 diabetes
    Andreasen, Christine R.
    Andersen, Andreas
    Hagelqvist, Per G.
    Lauritsen, Julius, V
    Jorgensen, Peter G.
    Engberg, Susanne
    Faber, Jens
    Hartmann, Bolette
    Pedersen-Bjergaard, Ulrik
    Knop, Filip K.
    Vilsboll, Tina
    DIABETES OBESITY & METABOLISM, 2022, 24 (10): : 2027 - 2037
  • [5] Prevalence of impaired awareness of hypoglycaemia and frequency of hypoglycaemia in insulin-treated Type 2 diabetes
    Schopman, Josefine E.
    Geddes, Jacqueline
    Frier, Brian M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) : 64 - 68
  • [6] Glucagon for hypoglycaemia treatment in type 1 diabetes
    Ranjan, Ajenthen G.
    Schmidt, Signe
    Norgaard, Kirsten
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (05)
  • [7] Exercise-induced hypoglycaemia in type 1 diabetes
    Cockcroft, E. J.
    Narendran, P.
    Andrews, R. C.
    EXPERIMENTAL PHYSIOLOGY, 2020, 105 (04) : 590 - 599
  • [8] Patient experience of hypoglycaemia unawareness in Type 1 diabetes: are patients appropriately concerned?
    Rogers, H. A.
    de Zoysa, N.
    Amiel, S. A.
    DIABETIC MEDICINE, 2012, 29 (03) : 321 - 327
  • [9] Effect of short-term use of dapagliflozin on impaired awareness of hypoglycaemia in people with type 1 diabetes
    van Meijel, Lian A.
    Tack, Cees J.
    de Galan, Bastiaan E.
    DIABETES OBESITY & METABOLISM, 2021, 23 (11): : 2582 - 2589
  • [10] Impaired hormonal counterregulation to biochemical hypoglycaemia does not explain the high incidence of severe hypoglycaemia during pregnancy in women with type 1 diabetes
    Ringholm, Lene
    Pedersen-Bjergaard, Ulrik
    Thorsteinsson, Birger
    Boomsma, Frans
    Rehfeld, Jens F.
    Damm, Peter
    Mathiesen, Elisabeth R.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2013, 73 (01): : 67 - 74